comprehensive -WSS

comprehensive

author：comprehensive 2025-09-30 19:03:23 - browse：3475

In this photo illustration, Farxiga, Xarelto, Entresto, and Eliquis are made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. These are 4 of 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. The other drugs include Jardiance, Enbrel, Januvia, Imbruvica, Stelara and Fiasp. — Scott Olson/Getty Images

WASHINGTON — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.

The offers will not be made public unless a manufacturer chooses to publicly disclose information about the talks, a senior administration official said. Companies have until March 2 to either accept the government’s offer or propose a counteroffer. The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends.

The negotiated prices won’t take effect until 2026.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Alzheimer's risk factor APOE4 may be a distinct form of the disease

focus

WSS

Mass General, Mayo Clinic look to monetize custom

Florida Supreme Court upholds state's abortion ban

Four alarming medical procedures we’re glad history forgot

Covid silver lining: Unprecedented look at human immune system

Alzheimer's risk factor APOE4 may be a distinct form of the disease

High breast density mammograms need follow

focus

comprehensive

leisure time

Cancer drug shortages should be causing more outrage

Maisha Meds is a PBM, but don't call it that

Medicare details structure of new drug price negotiation program

Bird flu in dairy cattle: New measures to control spread to humans

Hollywood unions extend contract negotiations for actors

FDA sets aggressive timeline for overhauling inspection procedures

Medicare details structure of new drug price negotiation program

CVS is on a mission to consolidate health care. Will it work?

Apple is now the first public company to be valued at $3 trillion

Medicare bonuses could stop drug shortages under Senate plan

focus

Medicare Advantage 2025 payments will dip, Biden administration says

Study: Black kids more likely to die after surgery than white kids

High breast density mammograms need follow

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Head of FDA's diagnostics center, who led through Covid, retires

Researchers test human milk's ability to repair gut microbiome

explore

focus

Wikipedia

leisure time